Table 1.

Demographic and clinical characteristics of the study population.

	n	Age (years)	Sex (%)	Smoking	Clinical diagnosis		Positive skin prick test	Total IgE levels (kU/l)	Specific IgE levels (kUA/l)
Nonallergic control	10	45.8 ± 14.7	50% female	12.5% smoking	Non-allergic		100% Negative	175.0 ± 224.8	Olive pollen IgE: 0.1 ± 0.1
			50% male	87.5% non-smoking					Ole e 1 IgE: NA
Total Olive pollen-allergic subjects	19	32.2 ± 12.3*	64.7% female	16.7% smoking	32% Rhinitis and no asthma	33.3% mild allergy	100% Olea europaea 47.4% Phleum pratense, 26.3% Salsola kali, 21.1% Cupressus sempervirens, 21.1% Platanus acerifolia, 15.8% Pets (cat/dog), 15.8% Alternaria alternata, 10,53% Hymenoptera, 5.26% Food allergy: egg, 5.26% Parietaria judaica, 5.26% LTP	425.4 ± 599.3	Olive pollen IgE: 18.2 ± 27.6
			35.3% male	83.3% non-smoking	68% Asthma and rhinitis	66.7% moderate allergy			Ole e 1 IgE: 6.9 ± 9.9
•  Nonasthmatic Olive- pollen-allergic subjects	6	39.2 ± 13.0	33.3% female	50% smoking	100% Rhinitis	83.3% mild allergy	100% Olea europaea 50% Phleum pratense, 33.3% Hymenoptera, 16.6% LTP	282.1 ± 301.2	Olive pollen IgE: 18.4 ± 30.6
			66.7% male	50% non-smoking		16.7% moderate allergy			Ole e 1 IgE: 1.8 ± 3.6
•  Asthmatic Olive- pollen-allergic subjects	13	28.7 ± 10.8*	81.8% female	0% smoking	100% Asthma and rhinitis	8.3% mild allergy	100% Olea europaea 46.2% Phleum pratense, 38.5% Salsola kali, 30.8% Cupressus sempervirens, 30.8% Platanus acerifolia, 23.1% Pets (cat/dog), 23.1% Alternaria alternata, 7.7% Parietaria judaica, 7.7% Food allergy: egg	491.5 ± 697.1*	Olive pollen IgE: 18.1 ± 22.4
			18.2% male	100% non-smoking		91.7% moderate allergy			Ole e 1 IgE: 9.2 ± 11.0

NA: not applicable. *Statistically significant differences compared to nonallergic subjects (p < 0.05).